Literature DB >> 9733617

Protein kinase C activation during Ca2+-independent vascular smooth muscle contraction.

D C Throckmorton1, C S Packer, C M Brophy.   

Abstract

The cellular signaling mechanisms that modulate the sustained vascular smooth muscle contractions that occur in vasospasm are not known. We and others have hypothesized that a kinase cascade involving protein kinase C (PKC) modulates sustained vascular smooth muscle contraction. The purpose of this investigation was to develop a model in which the traditional contractile pathways involving myosin light chain phosphorylation are not activated and determine if the PKC pathway is activated under these conditions. The phosphorylation of caldesmon, myosin light chain (MLC20), and the specific PKC substrate, MARCKS (myristoylated, alanine-rich C-kinase substrate) was measured in bovine carotid arterial smoothmuscle (BCASM) stimulated with phorbol 12,13-dibutyrate (PDBu) under Ca2+-containing and Ca2+-free conditions. PDBu stimulation led to increases in caldesmon and MARCKS phosphorylation to the same degree in the presence or absence of Ca2+. PDBu stimulation but did not lead to increases in MLC20 phosphorylation over basal levels in Ca2+-free conditions. Immunoblot analysis of BCASM using PKC isoform-specific antibodies demonstrated the presence of one "Ca2+- dependent" PKC isoform: alpha, and two of the "Ca2+-independent" isoforms: epsilon and zeta. These data suggest that Ca2+-independent isoforms of PKC may play a role in the sustained phase of BCASM contractions through a kinase cascade that involves caldesmon and MARCKS phosphorylation but not MLC20 phosphorylation. Copyright 1998 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9733617     DOI: 10.1006/jsre.1998.5368

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  8 in total

1.  A role for focal adhesion kinase in facilitating the contractile responses of murine gastric fundus smooth muscles.

Authors:  Yeming Xie; Koon Hee Han; Nathan Grainger; Wen Li; Robert D Corrigan; Brian A Perrino
Journal:  J Physiol       Date:  2018-04-06       Impact factor: 5.182

Review 2.  O-GlcNAcylation: a novel pathway contributing to the effects of endothelin in the vasculature.

Authors:  Victor V Lima; Fernanda R Giachini; David M Hardy; R Clinton Webb; Rita C Tostes
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2010-11-10       Impact factor: 3.619

3.  Acute impairment of contractile responses by 17beta-estradiol is cAMP and protein kinase G dependent in vascular smooth muscle cells of the porcine coronary arteries.

Authors:  Wendy Keung; Paul M Vanhoutte; Ricky Y K Man
Journal:  Br J Pharmacol       Date:  2005-01       Impact factor: 8.739

4.  siRNA-mediated knockdown of h-caldesmon in vascular smooth muscle.

Authors:  Elaine M Smolock; Danielle M Trappanese; Shaohua Chang; Tanchun Wang; Paul Titchenell; Robert S Moreland
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-09-18       Impact factor: 4.733

5.  Expression of the fast twitch troponin complex, fTnT, fTnI and fTnC, in vascular smooth muscle.

Authors:  Carlos M Moran; Robert J Garriock; Melanie K Miller; Ronald L Heimark; Carol C Gregorio; Paul A Krieg
Journal:  Cell Motil Cytoskeleton       Date:  2008-08

6.  Alpha 1-adrenoceptor effects mediated by protein kinase C alpha in human cultured prostatic stromal cells.

Authors:  A Preston; J M Haynes
Journal:  Br J Pharmacol       Date:  2003-01       Impact factor: 8.739

7.  Sustained Contraction in Vascular Smooth Muscle by Activation of L-type Ca2+ Channels Does Not Involve Ca2+ Sensitization or Caldesmon.

Authors:  Hillevi K Ets; Chun Y Seow; Robert S Moreland
Journal:  Front Pharmacol       Date:  2016-12-26       Impact factor: 5.810

8.  Protein kinase Cα stimulates hypoxia‑induced pulmonary artery smooth muscle cell proliferation in rats through activating the extracellular signal‑regulated kinase 1/2 pathway.

Authors:  Rui Jiang; Yiwei Shi; Chao Zeng; Wenyan Yu; Aizhen Zhang; Yongcheng Du
Journal:  Mol Med Rep       Date:  2017-09-12       Impact factor: 2.952

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.